Bristol-Myers Squibb is to buy US biotech Padlock Therapeutics, which aims to create treatments for serious autoimmune diseases, in a deal worth up to $600 million.

While choosing a padlock factors such as value of the articles to secure, material of the padlock and its shackle, size of the padlock, length of the shackle and the type of lock need to be paid ...